• May 13, 2025 Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full Potential of CAR-T Therapy

• Nov 12, 2024 Hyku Biosciences Appoints John Gustofson to its Board of Directors
• Oct 30, 2024 Chugai Venture Fund Announces the First Investment Agreement with Leal Therapeutics

• Jun 27, 2023 Chugai Establishes Corporate Venture Capital to Accelerate Innovation Opportunities with Drug Discovery Start-ups